- Genetic Variants Found to Reduce Effectiveness of GLP-1 Drugs in 10 Percent of Type 2 Diabetes Patients geneonline.com
- Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle NDTV
- Genetic predictors of GLP1 receptor agonist weight loss and side effects Nature
- New Nature study could someday lead to DNA test that predicts which anti-obesity drug works for you ThePrint
- Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs Medical Xpress
Genetic Variants Found to Reduce Effectiveness of GLP-1 Drugs in 10 Percent of Type 2 Diabetes Patients geneonline.comStruggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle NDTVGenetic predictors of GLP1 receptor agonist weight loss and side effects NatureNew Nature study could someday lead to DNA test that predicts which anti-obesity drug works for you ThePrintGenetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs Medical Xpress by Soban News (international And National News)